P1‐55: Pulmonary function after nintedanib treatment in post‐COVID‐19 pulmonary fibrosis

Chest CT scan showed extensive fibrosis for which she received methylprednisolone and physical therapy, eventually weaning her off HFNC but still with persistence of dyspnea on mild exertion. 1 Philippine General Hospital, Philippines, 2 St Lukes Medical Center, Philippines Physicians worldwide have been reporting substantial cases of post-COVID-19 pulmonary fibrosis. In conclusion, Nintedanib improved pulmonary function and chest CT findings in post-COVID-19 pulmonary fibrosis. [Extracted from the article] Copyright of Respirology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all Abstracts.)